Article

Keith Dunleavy, MD, Speaks About Health and Data Research

Keith Dunleavy, MD, President and CEO, Inovalon, discusses the importance of comparative effectiveness research in order to improve chronic disease management at both the individual and population levels.

Keith Dunleavy, MD, President and CEO, Inovalon, discusses the importance of comparative effectiveness research in order to improve chronic disease management at both the individual and population levels. Dr. Dunleavy also addresses decision support through target interventions.

Related Videos
Jonathan Eisengart
Tiago Biachi, MD, PhD
Irina Dralyuk
Edgardo S. Santos, MD, FACP, FASCO
Irina Dralyuk
Keith Ferdinand, MD, professor of medicine and the Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine
Robin Glasco, Spencer Stuart
Edgardo S. Santos, MD, FACP, FASCO
Tiago Biachi, MD, PhD
Don M. Benson, MD, PhD, James Cancer Hospital
Related Content
Karen Winkfield, MD, PhD, Vanderbilt University Medical Center
January 15th 2025

Building Trust Through Community Engagement in Cancer Care

Maggie L. Shaw
In part 2 of our interview with Karen Winkfield, MD, PhD, she speaks to the importance of ensuring health care accessibility and of knowing that the health care system is not a one-size-fits-all arrangement.
Managed Care Cast
January 14th 2025

Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy

Giuliana Grossi
Jessica Tracy, head of Growth and Partnerships at Enthea, shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.
Marie-France Jilderda, MD, PhD Candidate Surgical Oncology at Leiden University Medical Center in the Netherlands.
January 13th 2025

Identifying Patients With Low-Risk Breast Cancer for De-escalated Therapy

Cameron Santoro
A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially benefit from shorter or less-intensive treatment.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Travis Osterman, DO, MS, FAMIA, FASCO
January 9th 2025

AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers

Maggie L. Shaw
In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Oscar B. Lahoud, MD, NYU Langone Health
January 7th 2025

Transparency in Drug Pricing Key to Reducing Patient Burden

Maggie L. Shaw
Cochair of our recent Institute for Value-Based Medicine® event hosted with NYU Langone Health, Oscar B. Lahoud, MD, speaks on his hoped-for top health care priorities under the incoming administration.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo